Zhuhai Meiyi Biotechnology Co, Ltd was founded in 1997 by Chua Keng Hiang, a financing expert from Singapore. It is a comprehensive high-tech enterprise that integrates research and development, production, and sale of cosmetics. The company has a high-level scientific research and technology team as well as an excellent marketing team.

In 1992, the bFGF vaccine was introduced to China for the first time. In 1997, Meiyi was the first to develop a freeze-dried powder containing gene-engineered bFGF, which pioneered the field of biological beauty in China. Over the past years, with its outstanding quality, technology, education, and talent advantages in the industry, the company has created multiple well-known brands and solved skin problems for millions of loyal consumers. It is particularly well-regarded in the field of skin repair, and has established a leading position in China's professional beauty and cosmetics industry.